Legal Marketing & PR

Coming soon ... Blawg Review #178
On Monday 22 September 2008 I'll be hosting Blawg Review #178 here at Freedom to Differ. This will be the third time I have hosted Blawg Review from Australia, with the previous two times being Blawg Review #85 and Blawg Review #136...

Blawg Review #146
Welcome to Blawg Review #146. This is actually my second time hosting Blawg Review…I was party to the infamous Blawg Review #48 (hosted by the group blawg RethinkIP (with Matt and Doug )...

Blawg Review #167
The Blawg Review is a weekly review of the best law-related posts from a variety of blogs. We've had the pleasure of hosting the Blawg Review twice before (Blawg Review #103 and Blawg Review #140) and we're thrilled to be hosting Blawg Review #167...

Blawg Review #152
Blawg Review #152, TechnoLawyer Style Blawg Review is not just a blog, it's a clever social networking concept. Every week, a different blawg hosts Blawg Review, pointing out what it deems the most interesting blawg Posts from the previous week...

Blawg Review #178
G'day and welcome back down under! This is the third time I have hosted Blawg Review from Australia (the other two times were Blawg Review #85 and Blawg Review #136). For those who don't know, the Blawg Review is a weekly round-up of posts from around the blawgosphere...

Blawg Review #165
I am delighted to host this week?s Blawg Review. Bienvenue sur French-law.net! About Blawg Review: Blawg Review is the blog carnival for everyone interested in law. A peer-reviewed blog carnival, the host of each Blawg Review decides which of the submissions and recommended posts are suitable for inclusion in the presentation.

FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review

Aurora Loan Faces Class Action over Mortgage Review Services
Aurora Loan Faces Class Action over Mortgage Review Services

FDA Review of Prostate Cancer Treatment Prompts Warning of Risk for Diabetes
Prostate Cancer Treatment FDA Review Prompts Warning of Risk for Diabetes

Xigris
Study Prompts FDA Safety Review

Lipitor
Review of Studies Show No Significant Benefit in Women

Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports